Manufacturer record
Vivimed Labs Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Vivimed Labs Limited (Telangana) were declared Not of Standard Quality between August 2020 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AAC5066, Aspirin Gastro-resistant and Atorvastatin Capsules IP (75 mg/10 mg) (exp Jul 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Test for Dissolution of Aspirin and Atorvastatin. Listed in the August 2026 alert.
Records by type
9 records linked to Vivimed Labs Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75 mg/10 mg) | Batch AAC5066Mfg Aug 2025 · Exp Jul 2027 | Test for Dissolution of Aspirin and AtorvastatinDissolution | DTL, Bengaluru, KarnatakaState lab | Aug 2026 |
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) | Batch AAC5053Mfg Jul 2025 · Exp Jun 2027 | The sample does not conforms to I.P.2022 with respect to the Test for Related substances for Aspirin and Atorvastatin.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Ear wax softening drops, | Batch 5CU01Mfg Mar 2025 · Exp Feb 2027 | The sample received does not conform to manufacturer?s specification with respect to the test for Assay for the contents of Paradichlorobenzene, Chlorbutol and Turpentine OIL only.Assay | CDTL, HyderabadCDSCO lab | Mar 2026 |
| Paracetamol Paediatric Oral Suspension IP | Batch V0244001Mfg Feb 2024 · Exp Jan 2026 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Sep 2024 |
| Tropicamide Eye Drops IP 1 % w/v | Batch GTC002Mfg May 2022 · Exp Apr 2024 | Sterility & AssayAssay | CDTL MumbaiCDSCO lab | Jul 2023 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | Batch TE2027AMfg May 2022 · Exp Apr 2024 | DescriptionDescription | CDL KolkataCDSCO lab | Jan 2023 |
| FERROUS ASCORBATE & FOLIC ACID CAPSULES | Batch 1013Mfg Dec 2021 · Exp Nov 2023 | AVERAGE FILL AND ASSAY FOLIC ACIDAssay | CDTL HyderabadCDSCO lab | Dec 2022 |
| Ranitidine Oral Solution I.P. 100mL | Batch 2005Mfg Feb 2022 · Exp Jul 2023 | ASSAYAssay | RDTL GuwahatiState lab | Nov 2022 |
| Winpress-XL 5mg (Prazosin Hydrochloride Sustained Release Tablets) | Batch PST9001Mfg Feb 2019 · Exp Jan 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.